"Pharmaceutical Sales Force Structures & Strategies 1999-2000," a survey of U.S. physicians released by Newtown, PA-based pharmaceutical consulting company Scott-Levin, reveals that doctors rank Pfizer Inc.'s sales force as the most valuable. Twenty-eight physician specialty groups in nine core specialty areas – general/family practitioners, internists, pediatricians, orthopedic surgeons, obstetricians/gynecologists, psychiatrists, general surgeons, gastroenterologists and cardiologists – were surveyed for this year's study. 1999 was the fifth consecutive year New York-based Pfizer finished first across the core groups.
"Pharmaceutical Sales Force Structures & Strategies 1999-2000," a survey of U.S. physicians released by Newtown, PA-based pharmaceutical consulting company Scott-Levin, reveals that doctors rank Pfizer Inc.'s sales force as the most valuable. Twenty-eight physician specialty groups in nine core specialty areas â general/family practitioners, internists, pediatricians, orthopedic surgeons, obstetricians/gynecologists, psychiatrists, general surgeons, gastroenterologists and cardiologists â were surveyed for this year's study. 1999 was the fifth consecutive year New York-based Pfizer finished first across the core groups.
"Our annual survey has clearly established Pfizer's sales force as the industry leader," said Joy Scott, chief executive officer of Scott-Levin. "Firms with strong reputations for innovation and professionalism tend to perform better in the overall company rankings."
Karen Katen, president of U.S. Pharmaceuticals, Decatur, GA, and executive vice president of Pfizer Pharmaceuticals Group, said she was pleased with the results of the study. "Our sales representatives are on the front line in communicating advances in the understanding and treatment of diseases to millions of healthcare providers," she said. "The success of all of our products â whether internally developed or copromoted with partners â is substantially driven by the quality of their efforts."
The leading sales forces in other specialty groups were:
•Â Allergan: opthalmologists.
•Â Bristol-Myers Squibb: endocrinologists, oncologists, hematologists.
•Â Glaxo Wellcome: neurologists.
•Â Merck: cardiologists, pulmonologists, nephrologists, neurosurgeons.
•Â Wyeth-Ayerst: OB/GYNs. PR
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
Recent Developments in Pharmaceutical Validation
November 1st 2024Explore the latest pharmaceutical validation developments with industry experts from Barry-Wehmiller Design Group, Kneat Solutions, and No Deviation. You’ll gain valuable data-driven insights and discover emerging trends from the State of Validation 2024 industry report that are shaping the validation landscape.